Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

PHASE4CompletedINTERVENTIONAL
Enrollment

564

Participants

Timeline

Start Date

February 9, 2011

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Breast Neoplasms
Interventions
DRUG

Aromasin (exemestane)

the dosage, frequency and duration base on the LPD approved by SFDA.

Trial Locations (53)

100021

Cancer Hospital Chinese Academy of medical sciences, Beijing

100071

Fifth Medical Center of the PLA General Hospital, Beijing

100142

Beijing Cancer Hospital, Beijing

100191

Peking University Third Hospital/Department of Oncology, Beijing

110032

The Fourth Affiliated Hospital Of China Medical University, Shenyang

130021

The first hospital of jilin university, Changchun

150081

Harbin Medical University Cancer Hospital, Harbin

200032

Fudan University Shanghai Cancer center/Department of Breast Surgery, Shanghai

200090

Yangpu District Central Hospital, Shanghai

200092

Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai

210000

Jiangsu Cancer Hospital/ Surgery Department, Nanjing

210002

Jinling Hospital, Nanjing

210029

Jiangsu Province Hospital/ Surgery Department, Nanjing

213004

Changzhou No.2 People's Hospital, Changzhou

215002

Suzhou Municipal Hospital, Suzhou

230022

The First Affiliated Hospital of Anhui Medical University, Hefei

230601

Second Affiliated hospital of Anhui Medical University, Hefei

233004

The First Affiliated Hospital of Bengbu Medical College/Medical Oncology Department, Bengbu

255036

Breast and thyroid surgery of Central Hospital of Zibo, Zibo

261041

Breast Surgery of The Weifang People's Hospital, Weifang

264000

Breast Surgery of YanTai Yu Huang Ding Hospital, Yantai

266061

The Affiliated Hospital of Qingdao University, Qingdao

266072

Qingdao municipal Hospital, Qingdao

276000

Linyi People's Hospital, Linyi

300060

Tianjin Cancer Hospital/Breast cancer department, Tianjin

310022

Zhejiang Cancer Hospital, Hangzhou

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

410005

Hunan Provincial People's Hospital, Changsha

410008

Xiangya Hospital Central South University /Department of Breast, Changsha

430014

Breast and thyroid surgery of the Central Hospital of WuHan, Wuhan

434020

Jingzhou Hospital Tongji Medical College Huazhong university of science and Technology, Jingzhou

450000

Henan Cancer Hospital, Zhengzhou

Henan provincial people's hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

453100

The First Affiliated Hospital of Xinxiang Medical University, Weihui

510260

Breast Surgery of The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

SUN YAT-SEN Memorial Hospital , SUN YAT-SEN University, Guangzhou

515041

Cancer Hospital of Shantou University Medical College, Shantou

518035

Thyroid and breast surgery, Shenzhen

524001

Affiliated hospital of Guangdong medical college, Zhanjiang

570311

Hainan General Hospital, Haikou

610041

West China Hospital, Sichuan University/ Oncology Department, Chengdu

610072

Sichuan Provincial People's Hospital, Chengdu

637000

Affiliated Hospital of North Sichuan Medical College, Nanchong

650118

Yunnan Cancer Hospital, Kunming

710032

The First Affiliated Hospital of The Fourth Military Medical University, Xi'an

710061

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

730000

The First hospital of LanZhou university, Lanzhou

830000

Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi

050011

Fourth Hospital of Hebei Medical University, Shijiazhuang

010021

The Affiliated Hospital of inner Mongolia medical university, Hohhot

Unknown

Nanjing Maternity and Child Health Care Hospital/Department of Breast Surgery, Nanjing

China-Japan Friendship Hospital, Beijing

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY